3 results
The primary objective of this study is to evaluate the hypothesis that cixutumumab given in combination with cisplatin and pemetrexed is superior to cisplatin and pemetrexed as first-line therapy for patients with advanced nonsquamous non-small cell…
To investigate the efficacy and safety of BIBF 1120 as compared to placebo in patients with stage IIIB/IV or recurrent non small cell lung cancer treated with standard therapy of pemetrexed after failure of first line chemotherapy.
The main objective of this study is to determine whether use of the PReDicT Test to direct antidepressant treatmentresults in an increased proportion of depressed patients showing a response to treatment at week 8 compared toTreatment as Usual (TaU…